StockData
Quest Diagnostics Inc logo

Quest Diagnostics Inc (DGX) stock

DGXNYSEServices-Medical LaboratoriesFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 23, 2026Score 12/308% above fair value
$256.35−5.86 (-2.23%)

Close on Nov 17, 2026Market cap $28.20BP/E 25.6Yield –

Quest Diagnostics market cap

Market capitalization is the share price multiplied by the number of shares outstanding.

Quest Diagnostics's market cap was $29.10B on Nov 11, 2026, against $21.52B a year earlier. Over the last 5 years it ranged from $14.01B to $29.10B, with a median of $17.60B.

Market Cap at the end of each year

PeriodPeriod endValueChange
2026Nov 11, 2026$29.10B+47.4%
2025Dec 31, 2025$19.74B+17.1%
2024Dec 31, 2024$16.86B+7.3%
2023Dec 29, 2023$15.72B-16.8%
2022Dec 30, 2022$18.89B-16.5%
2021Dec 31, 2021$22.62B+39.6%
2020Dec 31, 2020$16.21B+10.8%
2019Dec 31, 2019$14.63B+26.2%
2018Dec 31, 2018$11.60B-15.9%
2017Dec 29, 2017$13.79B+4.7%
2016Dec 30, 2016$13.16B+27.4%
2015Dec 31, 2015$10.33B+5.9%
2014Dec 31, 2014$9.76B+16.9%
2013Dec 31, 2013$8.35B-10.4%
2012Dec 31, 2012$9.32B-3.7%
2011Dec 30, 2011$9.68B-0.8%
2010Dec 31, 2010$9.77B+13.7%
2009Dec 31, 2009$8.59B–

More Quest Diagnostics figures

See a number that looks wrong?